divis laboratories
Jump to
722 Results Found
  • Buy Divis Laboratories: target of Rs 3800: Sharekhan Nov 11, 2020 11:30 AM IST

    Buy Divis Laboratories: target of Rs 3800: Sharekhan

    Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06, 2020.

  • Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal Nov 10, 2020 12:12 PM IST

    Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated November 08, 2020.

  • Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market Nov 09, 2020 01:38 PM IST

    Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08, 2020.

  • Buy Divi's Laboratories; target of Rs 4205: ICICI Direct Nov 09, 2020 11:52 AM IST

    Buy Divi's Laboratories; target of Rs 4205: ICICI Direct

    ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated November 08, 2020.

  • Divi's Laboratories Q2 net profit up 46% at Rs 520 crore Nov 07, 2020 04:31 PM IST

    Divi's Laboratories Q2 net profit up 46% at Rs 520 crore

    The company had posted a net profit of Rs 356.78 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to BSE.

  • SBI Life, Divis Labs to replace Bharti Infratel, ZEE in Nifty50 Aug 20, 2020 08:48 PM IST

    SBI Life, Divis Labs to replace Bharti Infratel, ZEE in Nifty50

    SBI Life would be the second insurance company to enter into Nifty50 after HDFC Life Insurance Company which included in the index from July 31

  • Buy Divi’s Laboratories; target of Rs 3350: Motilal Oswal Aug 11, 2020 06:59 PM IST

    Buy Divi’s Laboratories; target of Rs 3350: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3350 in its research report dated August 09, 2020.

  • Buy Divis Laboratories; target of Rs 3400: Sharekhan Aug 11, 2020 06:58 PM IST

    Buy Divis Laboratories; target of Rs 3400: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated August 07, 2020.

  • Ideas for Profit | Is Divi’s Labs expensive for a reason? Aug 10, 2020 10:28 PM IST

    Ideas for Profit | Is Divi’s Labs expensive for a reason?

    In this edition of Ideas for Profit, CNBC-TV18's Sonal Bhutra sums up all the key takeaways from the first-ever conference call from the largest API manufacturer of India and evaluates what is in store for investors

  • Buy Divi's Laboratories; target of Rs 3260: ICICI Direct Aug 10, 2020 01:01 PM IST

    Buy Divi's Laboratories; target of Rs 3260: ICICI Direct

    ICICI Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 3260 in its research report dated August 09, 2020.

  • Divis Labs shares rally 12% as Q1 profit spikes 81%; HSBC raises target to Rs 2,755 Aug 10, 2020 10:10 AM IST

    Divis Labs shares rally 12% as Q1 profit spikes 81%; HSBC raises target to Rs 2,755

    The pharma company reported 80.61 percent rise in consolidated net profit at Rs 492.06 crore for June quarter 2020 mainly on account of robust sales.

  • Divis Labs Consolidated June 2020 Net Sales at Rs 1,730.47 crore, up 48.81% Y-o-Y Aug 10, 2020 09:44 AM IST

    Divis Labs Consolidated June 2020 Net Sales at Rs 1,730.47 crore, up 48.81% Y-o-Y

  • Divis Labs Standalone June 2020 Net Sales at Rs 1,709.96 crore, up 50.01% Y-o-Y Aug 10, 2020 09:41 AM IST

    Divis Labs Standalone June 2020 Net Sales at Rs 1,709.96 crore, up 50.01% Y-o-Y

  • Divi's Laboratories Q1 profit up 81% at Rs 492 crore Aug 08, 2020 02:00 PM IST

    Divi's Laboratories Q1 profit up 81% at Rs 492 crore

    The company logged a profit of Rs 272.44 crore in the year-ago same period, Divi's Laboratories said in a filing to BSE.

  • Buy Divis Laboratories target of Rs 2700: Sharekhan Jun 10, 2020 06:20 PM IST

    Buy Divis Laboratories target of Rs 2700: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated June 08, 2020.

  • Hold Divi's Laboratories; target of Rs 2355: ICICI Direct Jun 10, 2020 08:23 AM IST

    Hold Divi's Laboratories; target of Rs 2355: ICICI Direct

    ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 2355 in its research report dated June 09, 2020.

  • Divis Labs Consolidated March 2020 Net Sales at Rs 1,389.71 crore, up 9.67% Y-o-Y Jun 08, 2020 10:34 AM IST

    Divis Labs Consolidated March 2020 Net Sales at Rs 1,389.71 crore, up 9.67% Y-o-Y

  • Divis Labs Standalone March 2020 Net Sales at Rs 1,376.24 crore, up 9.54% Y-o-Y Jun 08, 2020 10:30 AM IST

    Divis Labs Standalone March 2020 Net Sales at Rs 1,376.24 crore, up 9.54% Y-o-Y

  • Divi's Laboratories Q4 net profit up 33% at Rs 388.23 crore Jun 06, 2020 05:29 PM IST

    Divi's Laboratories Q4 net profit up 33% at Rs 388.23 crore

    The company had posted a net profit of Rs 291.97 crore for the same period previous fiscal, Divi's Labs said in a BSE filing.

  • Divi's Laboratories begins commercial production at Visakhapatnam unit Mar 09, 2020 11:38 AM IST

    Divi's Laboratories begins commercial production at Visakhapatnam unit

    Divi's Laboratories, established in Hyderabad, is a pharmaceutical company with two manufacturing units.

  • Buy Divis Laboratories target of Rs 2430: Sharekhan Feb 24, 2020 10:40 AM IST

    Buy Divis Laboratories target of Rs 2430: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2430 in its research report dated February 20, 2020.

  • Buy Divi’s Laboratories target of Rs 2200: Sharekhan Feb 10, 2020 03:48 PM IST

    Buy Divi’s Laboratories target of Rs 2200: Sharekhan

    Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated February 06, 2020.

  • Divis Labs Consolidated December 2019 Net Sales at Rs 1,396.26 crore, up 2.67% Y-o-Y Feb 07, 2020 11:43 AM IST

    Divis Labs Consolidated December 2019 Net Sales at Rs 1,396.26 crore, up 2.67% Y-o-Y

  • Divis Labs Standalone December 2019 Net Sales at Rs 1,390.49 crore, up 3.54% Y-o-Y Feb 07, 2020 11:40 AM IST

    Divis Labs Standalone December 2019 Net Sales at Rs 1,390.49 crore, up 3.54% Y-o-Y

  • Divis Labs Standalone December 2019 Net Sales at Rs 1,390.49 crore, up 3.54% Y-o-Y Feb 06, 2020 11:40 AM IST

    Divis Labs Standalone December 2019 Net Sales at Rs 1,390.49 crore, up 3.54% Y-o-Y

Sections